ARC logo.png
Sperm Bank Market Value Anticipated To Reach US$ 4,900.0 Million By 2027 Covering COVID-19 Analysis: Acumen Research and Consulting
June 28, 2021 12:03 ET | Acumen Research and Consulting
LOS ANGELES, June 28, 2021 (GLOBE NEWSWIRE) -- The Global Sperm Bank Market is expected to grow at a CAGR of around 5.3% from 2020 to 2027 and reach the market value of over US$ 4,900.0 Mn by 2027. ...
Xphyto logo.jpg
InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Hugh Rogers, CEO of XPhyto Therapeutics Corp.
June 17, 2021 09:00 ET | XPhyto Therapeutics Corp.
NEW YORK, June 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...
QMI-Logo-Long-1000px.jpg
Global Biologics Safety Testing Market Size to Grow at a CAGR of 12.3% from 2021 to 2030
June 15, 2021 06:30 ET | Quince Market Insights
Pune, India, June 15, 2021 (GLOBE NEWSWIRE) -- The global biologics safety testing market has been estimated to reach USD 3.0 billion in 2021 and is projected to grow at a CAGR of 12.3% during the...
Nexen Tire ranks first in ACE Lenkrad summer tire test 2021
Nexen Tire ranks first in ACE Lenkrad summer tire test 2021
April 05, 2021 05:00 ET | Nexen Tire
SEOUL, South Korea, April 05, 2021 (GLOBE NEWSWIRE) -- Nexen Tire, a leading global tire manufacturer, today announced that the N'FERA Sport has earned first place in the summer tire test conducted...
Xphyto logo.jpg
XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Recent European Approval of 25-Minute COVID-19 PCR Test
March 29, 2021 08:30 ET | XPhyto Therapeutics Corp.
VANCOUVER, British Columbia, March 29, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on...
ibn-iw-globe-2.png
InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp.
March 12, 2021 08:17 ET | InvestorBrandNetwork (IBN)
LOS ANGELES, March 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...
logo-dark.png
Aegis Sciences Corporation and Walgreens announce expansion of COVID-19 diagnostic testing
February 11, 2021 08:00 ET | Aegis Sciences Corporation
NASHVILLE, Tenn. and DEERFIELD, Ill., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and...
FluroTech Logo.jpg
FluroTech Announces Appointment of Regulatory Consultant
January 14, 2021 08:45 ET | FluroTech Ltd.
CALGARY, Alberta, Jan. 14, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), is pleased to announce it has retained PandiaDx LLC (“PandiaDX”) for...
FluroTech Logo.jpg
FluroTech Announces Closing of First Tranche of Private Placement
January 11, 2021 08:45 ET | FluroTech Ltd.
CALGARY, Alberta, Jan. 11, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), is very pleased to announce that it has closed the first tranche of a...
FluroTech Logo.jpg
FluroTech Announces Exploration of Strategic Options for Cannabis Testing Business to Focus on Pandemic Defense System
December 18, 2020 18:00 ET | FluroTech Ltd.
CALGARY, Alberta, Dec. 18, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is exploring strategic alternatives for its Cannabis and Hemp testing...